Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription Articles published in BMJ Retrieve available abstracts of 93 articles: HTML format

Single Articles

April 2024
1. NOLAN T
   The use of continuous glucose monitoring devices in non-diabetic adults ... and other research.
   BMJ. 2024;385:q859.
   PubMed    
   
   
   
2. SETHI J
   Breaking free from the stigma of diabetes.
   BMJ. 2024;385:q890.
   PubMed    
   
   
   
3. BOKINNI Y
   Barbados is in the grip of a diabetic foot amputation crisis.
   BMJ. 2024;385:q350.
   PubMed    
   
   
   March 2024
4. CHRISTIE B
   Charity calls for Scottish government to increase access to diabetes technology.
   BMJ. 2024;384:q755.
   PubMed    
   
   
   
5. MAHASE E
   Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test.
   BMJ. 2024;384:q744.
   PubMed    
   
   
   
6. SAUL H, Deeney B, Swaithes L, Hounkpatin H, et al
   Even short periods of diabetes remission are linked to lower risk of heart attack and stroke.
   BMJ. 2024;384:q516.
   PubMed     Abstract available
   
   
   
7. TANNE JH
   FDA approves first over-the-counter blood glucose monitor for diabetes.
   BMJ. 2024;384:q611.
   PubMed    
   
   
   
8. TANNE JH
   US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDA.
   BMJ. 2024;384:q569.
   PubMed    
   
   
   February 2024
9. LANE MM, Gamage E, Du S, Ashtree DN, et al
   Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses.
   BMJ. 2024;384:e077310.
   PubMed     Abstract available
   
   
   
10. KIM KS, Hong S, Han K, Park CY, et al
    Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study.
    BMJ. 2024;384:e076388.
    PubMed     Abstract available
    
    
    
11. BHALA N
    Liver steatosis linked to type 2 diabetes outcomes.
    BMJ. 2024;384:q309.
    PubMed    
    
    
    January 2024
12. YAO H, Zhang A, Li D, Wu Y, et al
    Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis.
    BMJ. 2024;384:e076410.
    PubMed     Abstract available
    
    
    
13. SUBRAMANIAN S, Khan F, Hirsch IB
    New advances in type 1 diabetes.
    BMJ. 2024;384:e075681.
    PubMed     Abstract available
    
    
    
14. IACOBUCCI G
    Artificial pancreases for type 1 diabetes: Better access is "watershed moment"-but delivery is key.
    BMJ. 2024;384:q102.
    PubMed    
    
    
    
15. IACOBUCCI G
    Fragmented care is failing people with type 1 diabetes related eating disorders, inquiry finds.
    BMJ. 2024;384:q178.
    PubMed    
    
    
    
16. PHIZACKERLEY D
    Semaglutide reduces the absolute risk of major cardiovascular events by 1.5.
    BMJ. 2024;384:q53.
    PubMed    
    
    
    December 2023
17. COURCOULAS AP, Daigle CR, Arterburn DE
    Long term outcomes of metabolic/bariatric surgery in adults.
    BMJ. 2023;383:e071027.
    PubMed     Abstract available
    
    
    
18. COHEN D
    GLP-1 receptor agonists: European drug regulator asks makers for evidence of self-harm.
    BMJ. 2023;383:2906.
    PubMed    
    
    
    
19. CHEN TK, Hoenig MP, Nitsch D, Grams ME, et al
    Advances in the management of chronic kidney disease.
    BMJ. 2023;383:e074216.
    PubMed     Abstract available
    
    
    November 2023
20. IACOBUCCI G
    Challenges in diabetes and obesity: five minutes with . . . Jonathan Valabhji.
    BMJ. 2023;383:p2831.
    PubMed    
    
    
    
21. IACOBUCCI G
    England's diabetes prevention programme has delivered causal benefits, study reports.
    BMJ. 2023;383:p2691.
    PubMed    
    
    
    
22. MAHASE E
    NICE recommends hybrid closed loop systems for poorly controlled type 1 diabetes.
    BMJ. 2023;383:p2619.
    PubMed    
    
    
    October 2023
23. KAR P
    Partha Kar: The time to tackle rising type 2 diabetes is T2DaY.
    BMJ. 2023;383:p2490.
    PubMed    
    
    
    
24. LEE YJ, Hong SJ, Kang WC, Hong BK, et al
    Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.
    BMJ. 2023;383:e075837.
    PubMed     Abstract available
    
    
    
25. LADHER N, Hinton R, Veitch E
    Challenges of obesity and type 2 diabetes require more attention to food environment.
    BMJ. 2023;383:p2269.
    PubMed     Abstract available
    
    
    September 2023
26. WILL EJ
    SGLT2 inhibitors: here we go again?
    BMJ. 2023;382:2172.
    PubMed    
    
    
    
27. 
    Diagnosis and management of diabetes in children and young people: summary of updated NICE guidance.
    BMJ. 2023;382:p2072.
    PubMed    
    
    
    
28. FOU L, Agwu JC, Aswani N, Bakhai C, et al
    Glucose monitoring and glucose lowering agents for children and young people with type 2 diabetes: summary of updated NICE guidance.
    BMJ. 2023;382:p1686.
    PubMed    
    
    
    
29. MAHASE E
    Tirzepatide: NICE recommends another GLP-1 agonist for type 2 diabetes.
    BMJ. 2023;382:2074.
    PubMed    
    
    
    
30. IACOBUCCI G
    Diabetes: Doctors are told not to start new patients on GLP-1 agonists because of shortages.
    BMJ. 2023;382:2019.
    PubMed    
    
    
    July 2023
31. BRAITHWAITE B
    Risk of diabetes with statins: comparing apples with oranges.
    BMJ. 2023;382:p1720.
    PubMed    
    
    
    
32. IACOBUCCI G
    UK clinics told to stop prescribing antidiabetes drugs for weight loss, after shortages.
    BMJ. 2023;382:1693.
    PubMed    
    
    
    
33. HANNA F, Wu P, Heald A, Fryer A, et al
    Diabetes detection in women with gestational diabetes and polycystic ovarian syndrome.
    BMJ. 2023;382:e071675.
    PubMed     Abstract available
    
    
    June 2023
34. MAHASE E
    Tackling structural racism is crucial to ending global diabetes crisis, researchers say.
    BMJ. 2023;381:p1439.
    PubMed    
    
    
    
35. WISE J
    Covid-19: Metformin reduces the risk of developing long term symptoms by 40%, study finds.
    BMJ. 2023;381:p1306.
    PubMed    
    
    
    May 2023
36. GRAY M
    Preventing type 2 diabetes: public health campaigns should focus on living longer better.
    BMJ. 2023;381:p1139.
    PubMed    
    
    
    
37. MANSI IA, Sumithran P, Kinaan M
    Risk of diabetes with statins.
    BMJ. 2023;381:e071727.
    PubMed    
    
    
    
38. IACOBUCCI G
    Diabetes: Missed routine checks are causing premature deaths in England, charity warns.
    BMJ. 2023;381:1070.
    PubMed    
    
    
    
39. WHITE SL, Ayman G, Bakhai C, Hillier TA, et al
    Screening and diagnosis of gestational diabetes.
    BMJ. 2023;381:e071920.
    PubMed    
    
    
    April 2023
40. VALABHJI J, Kar P
    Rise in type 2 diabetes shows that prevention is more important than ever.
    BMJ. 2023;381:p910.
    PubMed    
    
    
    
41. 
    Rise in type 2 diabetes shows that prevention is more important than ever.
    BMJ. 2023;381:p941.
    PubMed    
    
    
    
42. SAUL H, Deeney B, Imison C, Tesfaye S, et al
    Combination therapy for painful diabetic neuropathy is safe and effective.
    BMJ. 2023;381:p866.
    PubMed     Abstract available
    
    
    
43. MA L, Hu Y, Alperet DJ, Liu G, et al
    Beverage consumption and mortality among adults with type 2 diabetes: prospective cohort study.
    BMJ. 2023;381:e073406.
    PubMed     Abstract available
    
    
    
44. FOROUHI NG
    Beverages and health outcomes in adults with type 2 diabetes.
    BMJ. 2023;381:p841.
    PubMed    
    
    
    
45. LYU H, Zhao SS, Zhang L, Wei J, et al
    Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study.
    BMJ. 2023;381:e073435.
    PubMed     Abstract available
    
    
    
46. WISE J
    Diabetes cases in UK reach all time high, charity warns.
    BMJ. 2023;381:p848.
    PubMed    
    
    
    
47. SHI Q, Nong K, Vandvik PO, Guyatt GH, et al
    Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2023;381:e074068.
    PubMed     Abstract available
    
    
    March 2023
48. MCCARTNEY M
    Semaglutide: should the media slim down its enthusiasm?
    BMJ. 2023;380:p624.
    PubMed    
    
    
    
49. WISE J
    Novo Nordisk suspended from industry body over serious breaches.
    BMJ. 2023;380:p634.
    PubMed    
    
    
    February 2023
50. CRUMP C, Sundquist J, McLaughlin MA, Dolan SM, et al
    Adverse pregnancy outcomes and long term risk of ischemic heart disease in mothers: national cohort and co-sibling study.
    BMJ. 2023;380:e072112.
    PubMed     Abstract available
    
    
    January 2023
51. IACOBUCCI G
    Type 1 diabetes: NICE recommends new "artificial pancreas" technology.
    BMJ. 2023;380:p55.
    PubMed    
    
    
    December 2022
52. XIE J, Wang M, Long Z, Ning H, et al
    Global burden of type 2 diabetes in adolescents and young adults, 1990-2019: systematic analysis of the Global Burden of Disease Study 2019.
    BMJ. 2022;379:e072385.
    PubMed     Abstract available
    
    
    November 2022
53. TAYLOR L
    Diabetes prevalence in Americas tripled in 30 years.
    BMJ. 2022;379:o2868.
    PubMed    
    
    
    
54. IACOBUCCI G
    Type 1 diabetes: US approves drug that can delay onset.
    BMJ. 2022;379:o2798.
    PubMed    
    
    
    
55. PRADHAN R, Lu S, Yin H, Yu OHY, et al
    Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study.
    BMJ. 2022;379:e071380.
    PubMed     Abstract available
    
    
    October 2022
56. MULVIHILL C, Brooks A, Basudev N, Lincoln P, et al
    Continuous glucose monitoring for adults and children with diabetes: summary of updated NICE guidance.
    BMJ. 2022;379:o2418.
    PubMed    
    
    
    
57. HUANG C, Wei K, Lee PMY, Qin G, et al
    Maternal hypertensive disorder of pregnancy and mortality in offspring from birth to young adulthood: national population based cohort study.
    BMJ. 2022;379:e072157.
    PubMed     Abstract available
    
    
    
58. IKOMI AE
    It's time to widen the capture of gestational diabetes in the UK.
    BMJ. 2022;379:o2444.
    PubMed    
    
    
    
59. DENG Y, Polley EC, Wallach JD, Dhruva SS, et al
    Emulating the GRADE trial using real world data: retrospective comparative effectiveness study.
    BMJ. 2022;379:e070717.
    PubMed     Abstract available
    
    
    September 2022
60. MAHASE E
    Type 1 diabetes: Global prevalence is set to double by 2040, study estimates.
    BMJ. 2022;378:o2289.
    PubMed    
    
    
    
61. YANG J, Qian F, Chavarro JE, Ley SH, et al
    Modifiable risk factors and long term risk of type 2 diabetes among individuals with a history of gestational diabetes mellitus: prospective cohort study.
    BMJ. 2022;378:e070312.
    PubMed     Abstract available
    
    
    
62. XIE W, Wang Y, Xiao S, Qiu L, et al
    Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis.
    BMJ. 2022;378:e070244.
    PubMed     Abstract available
    
    
    August 2022
63. MARSTON L
    The failed promise of the US's Inflation Reduction Act for patients with diabetes.
    BMJ. 2022;378:o2086.
    PubMed    
    
    
    
64. HUSSAIN Z
    NHS to rollout continuous glucose monitors for all patients with type 1 diabetes.
    BMJ. 2022;378:o1935.
    PubMed    
    
    
    July 2022
65. WISE J
    Covid-19: Infection raises risk of diabetes and heart disease diagnoses in following weeks, study finds.
    BMJ. 2022;378:o1838.
    PubMed    
    
    
    June 2022
66. HE L, Wang J, Ping F, Yang N, et al
    Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials.
    BMJ. 2022;377:e068882.
    PubMed     Abstract available
    
    
    
67. WISE J
    Type 2 diabetes: Charity warns of "perfect storm" putting more children at risk.
    BMJ. 2022;377:o1451.
    PubMed    
    
    
    
68. WISE J
    Diabetes drug results in substantial weight loss in people with obesity, study finds.
    BMJ. 2022;377:o1406.
    PubMed    
    
    
    May 2022
69. 
    Vitamin D and risk of type 2 diabetes.
    BMJ. 2022;377:o1326.
    PubMed    
    
    
    
70. YE W, Luo C, Huang J, Li C, et al
    Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis.
    BMJ. 2022;377:e067946.
    PubMed     Abstract available
    
    
    
71. KAWAHARA T, Suzuki G, Mizuno S, Inazu T, et al
    Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population.
    BMJ. 2022;377:e066222.
    PubMed     Abstract available
    
    
    
72. CHRISTIDES T
    Vitamin D and risk of type 2 diabetes.
    BMJ. 2022;377:o1166.
    PubMed    
    
    
    
73. RUSSELL EL
    Managing type 1 diabetes: have faith in patients.
    BMJ. 2022;377:o1240.
    PubMed    
    
    
    
74. ARMSTRONG GRAY T, Hussain S, Gray M
    Empower young people with type 1 diabetes.
    BMJ. 2022;377:o1237.
    PubMed    
    
    
    
75. MORAN GM, Bakhai C, Song SH, Agwu JC, et al
    Type 2 diabetes: summary of updated NICE guidance.
    BMJ. 2022;377:o775.
    PubMed    
    
    
    April 2022
76. 
    SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline.
    BMJ. 2022;377:o1080.
    PubMed    
    
    
    
77. SAUL H, Gursul D, Cassidy S, Sharpe D, et al
    Why don't children and young people engage with diabetes services?
    BMJ. 2022;377:o750.
    PubMed     Abstract available
    
    
    
78. NG SM, Corbett T, Doble E, Brooks A, et al
    Managing the psychosocial impact of type 1 diabetes in young people.
    BMJ. 2022;377:e070530.
    PubMed    
    
    
    March 2022
79. IACOBUCCI G
    All patients with type 1 diabetes in England should be offered continuous glucose monitoring, says NICE.
    BMJ. 2022;376:o834.
    PubMed    
    
    
    
80. DYER C
    Young man who refused treatment for suspected type 1 diabetes died before palliative care plan was put in place.
    BMJ. 2022;376:o787.
    PubMed    
    
    
    
81. HODKINSON A, Tsimpida D, Kontopantelis E, Rutter MK, et al
    Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis.
    BMJ. 2022;376:e067731.
    PubMed     Abstract available
    
    
    February 2022
82. MAHASE E
    Type 1 diabetes drug was withdrawn because of a "commercial conflict of interest," charity argues.
    BMJ. 2022;376:o373.
    PubMed    
    
    
    
83. TANNE JH
    Diabetes kills 100 000 Americans for second year in a row.
    BMJ. 2022;376:o300.
    PubMed    
    
    
    January 2022
84. MAHMOOD A, Dar S, Dabhad A, Aksi B, et al
    Advising patients with existing conditions about fasting during Ramadan.
    BMJ. 2022;376:e063613.
    PubMed    
    
    
    
85. 
    Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2022;376:o109.
    PubMed    
    
    
    
86. JAYEDI A, Soltani S, Motlagh SZ, Emadi A, et al
    Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies.
    BMJ. 2022;376:e067516.
    PubMed     Abstract available
    
    
    
87. SLUGGETT JK, Rigby D
    Simplifying medications for people with type 2 diabetes.
    BMJ. 2022;376:n3158.
    PubMed    
    
    
    December 2021
88. GAHUNGU N, Trueick R, Coopes M, Gabbay E, et al
    Paroxysmal atrial fibrillation.
    BMJ. 2021;375:e058568.
    PubMed    
    
    
    
89. BESSER REJ, Ng SM, Robertson EJ
    Screening children for type 1 diabetes.
    BMJ. 2021;375:e067937.
    PubMed    
    
    
    November 2021
90. NOLAN T
    Tom Nolan's research reviews-26 November 2021.
    BMJ. 2021;375:n2938.
    PubMed    
    
    
    
91. AUBERT CE, Lega IC, Bourron O, Train AJ, et al
    When and how to deintensify type 2 diabetes care.
    BMJ. 2021;375:e066061.
    PubMed    
    
    
    October 2021
92. IACOBUCCI G
    One in 10 UK adults could have diabetes by 2030, warns charity.
    BMJ. 2021;375:n2453.
    PubMed    
    
    
    September 2021
93. SLIEKER RC, van der Heijden AAWA, Siddiqui MK, Langendoen-Gort M, et al
    Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    BMJ. 2021;374:n2134.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.